The company's pipeline contains three compounds that are scheduled to file their NADAs (the animal equivalent of an NDA) at some point in 2014. These include:
CereKin - a chewable beef-flavored formulation of diace...查看全文
格隆汇6月16日丨Kindred Biosciences(KIN.US)现报9.18美元,大涨44.79%,暂成交2.15亿美元,最新市值4.16亿美元,换手率高达71.76%。 此前,全球第四大动物保健公司礼来动保将以每股9.25美元的价格收购生物制药公司Kindred Biosciences。 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000092 Size: 36 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000091 Size: 27 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000090 Size: 36 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000089 Size: 34 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000088 Size: 28 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000087 Size: 27 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000086 Size: 20 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000085 Size: 15 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000084 Size: 5 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000083 Size: 5 KB 网页链接